AQ
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| A genetic polymorphism in the pannexin1 gene predisposes for the development of endothelial dysfunction with increasing BMI | Biomolecules |  | 2020 | 459 | 200 | ||
| Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function | International Journal of Cardiology |  | 2017 | 536 | 0 | ||
| Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury | Journal of Molecular and Cellular Cardiology | | 2016 | 590 | 1 | ||
| Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways | Thrombosis and haemostasis | | 2015 | 795 | 0 | ||
| Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice | Thrombosis and haemostasis | | 2014 | 793 | 0 | ||
| Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case | World journal of clinical cases | | 2014 | 670 | 0 | ||
| Inferior vena cava parameters predict re-admission in ischaemic heart failure | European journal of clinical investigation | | 2014 | 620 | 0 | ||
| Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis | Mediators of inflammation | | 2014 | 838 | 410 | ||
| Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines | European heart journal | | 2013 | 588 | 0 | ||
| Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity | Mediators of inflammation | | 2013 | 565 | 275 | ||
| Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome | Mediators of inflammation | | 2013 | 556 | 220 | ||
| The vulnerable coronary plaque: update on imaging technologies | Thrombosis and haemostasis | | 2013 | 454 | 0 | ||
| Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals | Mediators of inflammation | | 2012 | 655 | 310 | ||
| Coronary Vasomotor Control in Obesity and Morbid Obesity | JACC. Cardiovascular imaging | | 2012 | 764 | 692 | ||
| Statins in the treatment of acute ischemic stroke | Current pharmaceutical biotechnology | | 2012 | 517 | 0 | ||
| Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight | Journal of nuclear cardiology | | 2012 | 699 | 329 | ||
| Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability | Thrombosis and haemostasis | | 2012 | 797 | 0 | ||
| Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome | American journal of physiology: endocrinology and metabolism | | 2011 | 668 | 0 | ||
| Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity | European heart journal | | 2011 | 673 | 0 | ||
| Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling | European journal of clinical investigation | | 2010 | 568 | 0 | ||
| Novel treatment strategy with direct renin inhibition against heart failure | Panminerva Medica | 2010 | 490 | 0 | |||
| New evidence for nicotinic acid treatment to reduce atherosclerosis | Expert review of cardiovascular therapy | 2010 | 1,043 | 0 | |||
| Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD. Radiation exposure of 13N-ammonia PET/CT | Nuclear-Medizin | 2010 | 650 | 0 | |||
| Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS) | Sleep & breathing | | 2010 | 607 | 412 | ||
| Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT | Journal of nuclear cardiology | | 2010 | 678 | 269 | ||
| Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification | Critical pathways in cardiology | 2010 | 748 | 0 | |||
| Ezetimibe/simvastatin | Expert opinion on drug safety | | 2009 | 536 | 0 | ||
| Chlorhexidine prevents hypochlorous acid-induced inactivation of alpha1-antitrypsin | Clinical and experimental pharmacology & physiology | | 2009 | 719 | 0 | ||
| Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways | Journal of Biomedicine and Biotechnology | | 2009 | 536 | 0 |
